Somwaru Lily L, Arnold Alice M, Joshi Neha, Fried Linda P, Cappola Anne R
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
J Clin Endocrinol Metab. 2009 Apr;94(4):1342-5. doi: 10.1210/jc.2008-1696. Epub 2009 Jan 6.
Thyroid hormone use is common in older populations, but the frequency of over- or under-replacement is debated.
We sought to describe the frequency of and factors associated with thyroid hormone over- or under-replacement in a population of older men and women.
Participants were 3678 U.S. community dwelling individuals aged 65 yr or older enrolled in the Cardiovascular Health Study who had thyroid function tests in 1989-1990. Thyroid hormone users (n = 339) were identified and classified into low TSH (<0.45 mU/liter), euthyroid (0.45-4.5 mU/liter), and high TSH (>4.5 mU/liter).
Of the 339 thyroid hormone users, 41% had a low TSH, 16% had a high TSH, and 43% were in the euthyroid range. In multivariable analyses, lower weight (P < 0.001) was independently associated with low TSH status. For every 10 kg lower weight, the likelihood of having low TSH increased by 65% [odd ratio (OR) 1.65; 95% confidence interval (CI) 1.31-2.07]. Those with renal insufficiency were less likely to have low TSH levels (P = 0.02). The presence of diabetes was independently associated with having low (OR 3.35; 95% CI 1.46-7.65) and high TSH levels (OR 2.66; 95% CI 1.14-6.21).
There is a very high prevalence of thyroid function testing abnormalities in older people taking thyroid hormone preparations, particularly in those of low weight or with diabetes. Because of potential adverse cardiovascular and skeletal effects from over-replacement, older people represent a key population for increased TSH monitoring on therapy.
甲状腺激素在老年人群中使用普遍,但甲状腺激素替代过量或不足的频率存在争议。
我们试图描述老年男性和女性人群中甲状腺激素替代过量或不足的频率及相关因素。
参与者为3678名年龄在65岁及以上、居住在美国社区、参加心血管健康研究且在1989 - 1990年进行过甲状腺功能测试的个体。确定了甲状腺激素使用者(n = 339),并将其分为促甲状腺激素水平低(<0.45 mU/升)、甲状腺功能正常(0.45 - 4.5 mU/升)和促甲状腺激素水平高(>4.5 mU/升)三类。
在339名甲状腺激素使用者中,41%促甲状腺激素水平低,16%促甲状腺激素水平高,43%甲状腺功能正常。在多变量分析中,体重较低(P < 0.001)与促甲状腺激素水平低独立相关。体重每降低10千克,促甲状腺激素水平低的可能性增加65% [比值比(OR)1.65;95%置信区间(CI)1.31 - 2.07]。肾功能不全者促甲状腺激素水平低的可能性较小(P = 0.02)。糖尿病的存在与促甲状腺激素水平低(OR 3.35;95% CI 1.46 - 7.65)和促甲状腺激素水平高(OR 2.66;95% CI 1.14 - 6.21)独立相关。
服用甲状腺激素制剂的老年人中甲状腺功能测试异常的患病率非常高,尤其是体重低或患有糖尿病的老年人。由于替代过量可能对心血管和骨骼产生潜在不良影响,老年人是治疗期间加强促甲状腺激素监测的关键人群。